Clinical Trial Update: A Study of the Novel Drug Dimebon in Patients With Huntington's Disease [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical study evaluating Dimebon for Huntington's disease. No efficacy or safety results are provided in the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Dimebon (latrepirdine)

Snippet

Sponsor: Medivation, Inc. | Conditions: Huntington's Disease | Phase 2 | Status: COMPLETED